According to the latest report by IMARC Group, titled “Pharmaceutical Filtration Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the global pharmaceutical filtration market size reached US$ 11.2 Billion in 2022. Pharmaceutical filtration refers to the process of removing unwanted particles or contaminants from pharmaceutical products or their production environments using various filtration techniques. The primary objective is to eliminate impurities, such as microorganisms, particulate matter, endotoxins, and other unwanted substances that may compromise the integrity and purity of the pharmaceuticals. It plays a critical role in ensuring the safety, quality, and efficacy of pharmaceutical products. It is employed at various stages of the drug manufacturing process, including raw material purification, intermediate product processing, and final product filtration. Different filtration methods are utilized depending on the specific requirements of the pharmaceutical industry.
Global Pharmaceutical Filtration Market Trends:
Significant growth in the biopharmaceutical industry is driving the global market. Along with this, the increasing prevalence of chronic diseases among the masses is fuelling the market. Moreover, with the rising demand for parenteral drugs, injectable formulations, and aseptic processing, the need for reliable sterile filtration solutions is growing, which in turn impelling the demand for high-performance filters and filter media in the pharmaceutical industry. Besides this, continual technological advancements in filtration, including improved filter designs, innovative filter media, and advanced membrane technologies, which offer benefits, such as reduced processing time, improved product yield, and enhanced cost-effectiveness, are augmenting the adoption of advanced filtration solutions. Furthermore, the increasing focus on single-use technologies is catalyzing the market as these technologies offer advantages, such as reduced cross-contamination risks, simplified validation processes, and improved operational efficiency. Apart from this, the growing adoption of innovative treatment therapies, including therapeutic proteins, monoclonal antibodies, and vaccines, has led to increased utilization of filtration systems by biotechnology and biopharmaceutical companies. Looking forward, the market value is projected to reach US$ 35.7 Billion by 2028, expanding at a CAGR of 21.6% during 2023-2028.
- Based on the product, the market has been segmented into membrane filters (MCE, coated cellulose acetate, PTFE, nylon, PVDF, and other membrane filters), prefilters and depth media (glass and PTFE fiber filters), single-use systems, cartridges and capsules, filter holders, filtration accessories, and others.
- On the basis of the technique, the market has been divided into microfiltration, ultrafiltration, crossflow filtration, nanofiltration, and others.
- Based on the application, the market has been bifurcated into final product processing (active pharmaceutical ingredient filtration, sterile filtration, protein purification, vaccines and antibody processing, formulation and filling solutions, and viral clearance), raw material filtration (media buffer, pre-filtration, and bioburden testing), cell separation, water purification, and air purification.
- On the basis of the scale of operation, the market has been divided into manufacturing scale, pilot-scale, and research and development scale.
- Region-wise, the market has been segmented into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico and others) and the Middle East and Africa.
- The competitive landscape of the market has also been examined, with some of the key players being 3M Company, Amazon Filters Ltd, Danaher Corporation, Eaton Corporation plc, General Electric Company, Graver Technologies LLC, Meissner Filtration Products Inc, Merck KGaA, Parker Hannifin Corporation and Sartorius AG.
|Base Year of the Analysis
| Historical Period
||Product, Technique, Application, Scale of Operation, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||3M Company, Amazon Filters Ltd, Danaher Corporation, Eaton Corporation plc, General Electric Company, Graver Technologies LLC, Meissner Filtration Products Inc, Merck KGaA, Parker Hannifin Corporation and Sartorius AG
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800